Below, GSK CEO Emma Walmsley meets Baby KJ, the child who was treated with CRISPR gene editing by researchers at Children's Hospital of Philadelphia.
It was one of the biggest moment from #STATSummit. You can read about that moment and more here: www.statnews.com/2025/10/24/p...
Genentech, *the* original biotech company, is celebrating its 50th anniversary in 2026. VP, US External Affairs Joy Russell stopped by the STAT Brand Studio multimedia lounge at #statsummit to talk with Britt Whitmore about the company's past, present, future, and its patient impact.
Sometimes the biggest moments at a conference happen backstage. At the annual #STATSummit, that kind of moment involved a pharma CEO and a toddler in a tuxedo. www.statnews.com/2025/10/24/p...
This was one of the key moments for me from the #STATSummit last week.
At a gathering of biopharma executives, a moment of wonder — and also of worry
Industry confronts an era of innovation in the shadow of concerns about public trust, pricing
My takeaways from last week's #STATSummit
www.statnews.com/2025/10/24/p...
At the #STATSummit, Daniel Jernigan recounts what it was like at the CDC after a gunman had opened fire on the building.
YouTuber 'Doctor Mike' thinks medicine needs a better social media strategy
#STATSummit
www.statnews.com/2025/10/21/d...
Noubar Afeyan tells #STATSummit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s going to go to every medicine."
www.statnews.com/2025/10/20/m...
If people think the attack on scientific advances is going to stop with #mRNA vaccines, they should think again, a co-founder of Moderna warned last week at the #STATSummit. This is going to make it harder to treat a raft of common diseases, Noubar Afeyan warned. www.statnews.com/2025/10/20/m...
STAT's @matthewherper.bsky.social asks Eli Lily's Daniel Skovronsky about hiring Peter Marks and the revolving door of talent at the FDA.
#STATSummit
The US is currently a biotech leader, but the inconsistency at the FDA will make it hard to make new medicines.
“I think this is going to kill drug development,” Replimune CEO Sushil Patel told Adam Feuerstein at the #STATSummit.
The U.S. pharmaceutical industry is at a “Sputnik moment,” says Alnylam Pharmaceuticals founder John Maraganore.
“We need to think about the cost of our research and development activities and how to do it cheaper. We have to be competitive with what China is doing.”
#STATSummit
President Trump’s bid to lower drug prices for Americans, his most favored nation policy, “is pretty catastrophic for the industry,” said Biogen head Chris Viehbacher.
“We can’t just unwind years of how we’ve had to deal with governments.”
#STATSummit
Stephen M. Taylor, president of the American Society of Addiction Medicine, talks with STAT’s addiction reporter Lev Facher about medications for opioid use disorder vs. 12-step programs.
#STATSummit
Kyle Muldoon thought he might never get to watch an Eagles game with his son KJ, who was born with a rare and fatal liver disease that was treated with an individual CRISPR therapy.
#STATSummit
The technology that saved baby KJ was built over decades of basic science. Kiran Musunuru, a researcher at the University of Pennsylvania, breaks down everything that was needed to make sure KJ’s doctors could put together a treatment on demand. #STATSummit
At the STAT Summit, the former Democratic congressman from Massachusetts shared his concerns about the recent Medicaid cuts. www.statnews.com/2025/10/17/j...
#STATSummit
At #STATSummit, @joekennedyiii.bsky.social talks about the impact of community health centers.
"At one point, we sent doctors to communities to treat people. Now, we're sending the National Guard. Why?"
“I get asked this constantly: When will we start rebuilding? I don’t think we can know until we know the full extent of the destruction. There’s no reason to think we’ve bottomed out,” said former NIH institute leader Eric Green at #STATSummit this week. www.statnews.com/2025/10/16/f...
Read more about the technical difficulties in developing guidelines for Medicaid AI: www.statnews.com/2025/07/28/w... #STATSummit
Modifying Medicaid systems for a new task like implementing Medicaid work requirements is difficult.
“To call our IT systems dinosaurs would be charitable,” said Mike Levine, undersecretary at Massachusetts’ Medicaid organization MassHealth.
#STATSummit
Noubar Afeyan founded Flagship Pioneering, best known for its company Moderna, which commercialized mRNA vaccines.
Onstage at the #STATSummit, he lays out why the attack on mRNA undermines facts and science and isn’t going to stop at mRNA.
"Of all the different addictions, whether it's heroin and cocaine or alcohol ... gambling is the one that is most closely associated with suicidality." Stephen M. Taylor, American Society of Addiction Medicine president, at #STATSummit
Do we want Medicaid to be a social program, or do we want them to be an insurer, or do we want them to be both? I feel like that changes every four years, and states can't keep up with it. — Elizabeth Matney
"I think, at its core, the reason people fall off of coverage in these situations is because they don't understand how to interact with the systems in an effective way."
four people sit on the summit stage
Next up: Medicaid 2027
Current and former state Medicaid directors will map out the monumental task ahead as states prepare to roll out new federal work requirements and other provisions of the One Big Beautiful Bill.
@tarabannow.bsky.social moderates.
#STATSummit
Alondra Nelson Former Director White House Office of Science and Technology Policy, talked about how her military family and background always instilled the duty to serve — no matter the political party. Then she explained why she ultimately ended up having to leave.
#STATSummit
The American Medical Association president defended the physician group's restrained advocacy strategy toward the Trump administration. www.statnews.com/2025/10/16/a...
#STATSummit
Read more about Green’s ouster from the NIH earlier this year: www.statnews.com/2025/06/26/n...
#STATSummit
